You are using an outdated browser. Please upgrade your browser to improve your experience.

brentuximab vedotin

Ligand Summary
Description
a CD30-directed antibody-drug conjugate consisting of three components: the chimeric IgG1 antibody cAC10, specific for human CD30, the microtubule disrupting agent MMAE, and a protease-cleavable linker that covalently attaches MMAE to cAC10
Synonyms & Links
DrugCentral: 4964
LyCHI:  brentuximab vedotin


Target Activities